My Registrations

Shopping cart is empty.

Log-in Status

No one logged in. Log In

[ SBN Networking Event Fall 2018 ]


SBN Networking Event 2018 6PM, November 27th, 2018 Event Details here (


[ Building Biotech-Creating Opportunities in the BC Bioeconomy ]


Building Biotech 2018 Thursday, Sept 27, 6:00pm Coast Coal Harbour Hotel View Event Details (


[ Genome BC Poster Competition 2018 ]


Upcoming: Thursday, May 24th, 2018 UBC's Pharmaceutical Sciences-Atrium Event details here ( )...


[ Networking Night ]


Upcoming: Tuesday, July 26th, 2017 6:30-9:00 pm, Steamworks Brewpub View Event Details (


[ Annual General Meeting 2017 ]


Tuesday, June 27th, 2017 5:30-7:00 pm, at BC Cancer Research Centre, Dorothy Lam Boardroom, 1st floor View Event Details (


[ SBN Soiree 2017 ]


Wednesday June 7th, 2017 6:00pm-9:00 pm, at TELUS World of Science View Event Details (


[ Research Exchange & Poster Competition 2017 ]


Research Exchange & Poster Competition 2017 Thursday, May 25th, 2017 8:30am-4:00 pm, at UBC Pharmaceutical Sciences Building Main Foyer, 2405 Wesbrook Mall View Event D..


[ Networking Night ]


Upcoming: Thursday, April 20th, 2017 6:30PM - 9:00PM Central City Brewpub (Central City Shopping Centre, 13450 102 Ave) View Event Details (


[ Career Connect - CDRD ]


Upcoming: Tuesday, March 7 2017 1:30PM - 5:00PM; 2405 Wesbrook Mall, Vancouver View Event Details (


[ Biotech Expo 2017 ]


Upcoming: Thursday, February 23rd, 2017 5:30PM - 9:00PM Jack Poole Hall at the Robert H. Lee Alumni Center (6163 University Blvd) Event details here (


Creating Connections Between Chemistry, Biology and Industry: Designing Agents To Treat HIV/AIDS, Cancer, and Cardiovascular Diseases

Jan 24th 2011


SBN, in partnership with The University of Northern British Columbia, are co-hosting an exciting lecture focusing on the how small molecule library synthesis of biologically active molecules can be applied to the treatment of cancer, HIV/AIDS, cardiovascular disease and genetic disorders.  Find out about the science and strategy behind Dr. David Grierson’s success!

Time & Location:

Date: Monday, Jan 24th 2011 UNBC
Time: 3:30 - 5:00 PM
Location: Lecture Theatre 5-171, UNBC
Address:  University of Northern British Columbia, 3333 University Way, Prince George, BC, Canada, V2N 4Z9


Why students should attend?

  • To discover more out about small molecule inhibitors
  • To learn more about how small molecule libary synthesis of biologically active molecules can have applications for the treatment of many disesases 
  • To meet and network with other like minded students who share the same interests as you

Dr. David Grierson

Doctorat d'Etat ès-Sciences, Université de Paris-Sud (Orsay) France 1984
PhD, University of British Columbia 1975

Fascinated by the chemistry and structure of complex molecules in nature, David Grierson obtained his PhD degree in 1975 under the direction of Prof. J.P. Kutney in the Department of Chemistry at UBC. His thesis topic concerned the biosynthesis of a small group of indole alkaloids indigenous to certain South American plant species. Subsequently, as an NRC industrial Post-Doctoral fellow at Ayerst Laboratories in Montreal he worked on the synthesis of analogues of the endogenous opioid peptide enkephalin. He then moved to France as a CNRS (French National Scientific Research Centre) post doctoral fellow at the Natural Products Chemistry Laboratory (ICSN) at Gif-sur-Yvette (near Paris), where he developed, together with Dr. Henri-Philippe Husson, a new strategy for the synthesis of alkaloids. While waiting for a permanent CNRS position he worked in a French pharmaceutical company (Rousel-UCLAF) on a novel approach conceived by Prof. Sir Derek Barton to synthesize lysergic acid. In 1980 he integrated the CNRS, obtained a second Doctor degree and in 1985 became a Research Director. Over the next 12 years his research interests shifted toward medicinal chemistry, and in 1998 he joined the Curie Institute as a group leader, and subsequently as Director of the Medicinal Chemistry Laboratory (UMR176 CNRS). To foster the interaction with biologists, both at Institut Curie and across France working in the area of cancer, HIV/AIDS and other domains, he initiated the creation of the Institut Curie molecule library (8500 compounds) and established 23 collaborations to evaluate this library against 40 therapeutically relevant targets. In 2007 he moved to the Faculty of Pharmaceutical Sciences at UBC, where he is currently establishing a new research group and the critical collaborations essential to drug discovery. 


[ SBN would not be possible without its generous sponsors ]